Matinas BioPharma Announces Topline Results from ENHANCE-IT Study of LYPDISO™ Against Vascepa®

NEXT STORY
Global Medical Devices Market 2021 Size & Share | Market worth USD 612.7 Billion at 5.4% CAGR by 2025
PREV STORY
Coherus BioSciences to expand late-stage pipeline to immuno-oncology with in-license of Junshi Biosciences’ PD-1, toripalimab, in United States and Canada
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

G2 Bio Companies Launch with US$200 Million to Develop Transformative Genetic-Based Therapies

author_avatar
NASDAQ Market News

Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors

author_avatar
NASDAQ Market News

Roche presents exploratory data from the Phase III IMvigor010 study in early bladder cancer at the ESMO Immuno-Oncology Virtual Congress 2020

author_avatar
NASDAQ Market News